BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15206668)

  • 1. Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique.
    Rausch JL; Corley KM; Hobby HM
    J Clin Psychopharmacol; 2004 Apr; 24(2):209-13. PubMed ID: 15206668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM; Knight DL; Nemeroff CB
    Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
    Agnel M; Esnaud H; Langer SZ; Graham D
    Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram: a unique mechanism of action.
    Bræstrup C; Sanchez C
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
    Silanes SP; Orús L; Oficialdegui AM; Martínez Esparza J; Lasheras B; Del Río J; Monge A
    Pharmazie; 2004 Jul; 59(7):499-501. PubMed ID: 15296084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
    Kellner M; Demiralay C; Muhtz C; Husemann J; Kölsch W; Hiemke C; Yassouridis A; Wiedemann K
    Psychiatry Res; 2008 Dec; 161(3):339-43. PubMed ID: 18962988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER; Owen JA; Hudson RW; Delva NJ
    Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.
    Horschitz S; Hummerich R; Schloss P
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):728-32. PubMed ID: 11709064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE; Ressler KJ; Owens MJ
    Pharmacol Biochem Behav; 2016 Feb; 141():50-7. PubMed ID: 26621784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 3-[4-(3-substituted phenyl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Orús L; Martínez J; Pérez S; Oficialdegui AM; del Castillo JC; Mourelle M; Lasheras B; del Río J; Monge A
    Pharmazie; 2002 Aug; 57(8):515-8. PubMed ID: 12227188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There is a new antidepressant escitalopram (Lexapro) that is a cousin of citalopram (Celexa). How are these two different and does the newer drug have any advantages?
    Harv Ment Health Lett; 2003 Jul; 20(1):8. PubMed ID: 12888468
    [No Abstract]   [Full Text] [Related]  

  • 19. R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter.
    Stórustovu Sí; Sánchez C; Pörzgen P; Brennum LT; Larsen AK; Pulis M; Ebert B
    Br J Pharmacol; 2004 May; 142(1):172-80. PubMed ID: 15037515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
    Barker EL; Perlman MA; Adkins EM; Houlihan WJ; Pristupa ZB; Niznik HB; Blakely RD
    J Biol Chem; 1998 Jul; 273(31):19459-68. PubMed ID: 9677366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.